Hepatitis Monthly

Published by: Kowsar

A Novel Hydrodynamic Injection Mouse Model of HBV Genotype C for the Study of HBV Biology and the Anti-Viral Activity of Lamivudine

Xiumei Li 1 , Guangze Liu 1 , Meijuan Chen 1 , Yang Yang 1 , Yong Xie 1 and Xiangping Kong 1 , *
Authors Information
1 Liver Disease Key Lab, 458 Hospital of PLA, Guangzhou, China
Article information
  • Hepatitis Monthly: February 2016, 16 (2); e58764
  • Published Online: February 27, 2016
  • Article Type: Research Article
  • Received: November 12, 2015
  • Revised: January 6, 2016
  • Accepted: January 15, 2016
  • DOI: 10.5812/hepatmon.34420

To Cite: Li X, Liu G, Chen M, Yang Y, Xie Y, et al. A Novel Hydrodynamic Injection Mouse Model of HBV Genotype C for the Study of HBV Biology and the Anti-Viral Activity of Lamivudine, Hepat Mon. 2016 ;16(2):e58764. doi: 10.5812/hepatmon.34420.

Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Scaglione SJ, Lok AS. Effectiveness of hepatitis B treatment in clinical practice. Gastroenterology. 2012; 142(6): 1360-1368 e1[DOI][PubMed]
  • 2. Liu CJ, Kao JH. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J. Semin Liver Dis. 2013; 33(2): 97-102[DOI][PubMed]
  • 3. Malmstrom S, Eilard A, Larsson SB, Hannoun C, Norkrans G, Lindh M. Genotype impact on long-term virological outcome of chronic hepatitis B virus infection. J Clin Virol. 2012; 54(4): 321-6[DOI][PubMed]
  • 4. Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol. 2013; 28 Suppl 1: 7-10[DOI][PubMed]
  • 5. Kosaka K, Hiraga N, Imamura M, Yoshimi S, Murakami E, Nakahara T, et al. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections. Biochem Biophys Res Commun. 2013; 441(1): 230-5[DOI][PubMed]
  • 6. Roggendorf M, Yang D, Lu M. The woodchuck: a model for therapeutic vaccination against hepadnaviral infection. Pathol Biol (Paris). 2010; 58(4): 308-14[DOI][PubMed]
  • 7. Dandri M, Lutgehetmann M. Mouse models of hepatitis B and delta virus infection. J Immunol Methods. 2014; 410: 39-49[DOI][PubMed]
  • 8. Dandri M, Lutgehetmann M, Petersen J. Experimental models and therapeutic approaches for HBV. Semin Immunopathol. 2013; 35(1): 7-21[DOI][PubMed]
  • 9. Chayama K, Hayes CN, Hiraga N, Abe H, Tsuge M, Imamura M. Animal model for study of human hepatitis viruses. J Gastroenterol Hepatol. 2011; 26(1): 13-8[DOI][PubMed]
  • 10. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science. 1990; 247(4949 Pt 1): 1465-8[PubMed]
  • 11. Herweijer H, Wolff JA. Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Ther. 2007; 14(2): 99-107[DOI][PubMed]
  • 12. Chuai X, Wang W, Chen H, Deng Y, Wen B, Tan W. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection. Antiviral Res. 2014; 101: 68-74[DOI][PubMed]
  • 13. Shashidharamurthy R, Machiah D, Bozeman EN, Srivatsan S, Patel J, Cho A, et al. Hydrodynamic delivery of plasmid DNA encoding human FcgammaR-Ig dimers blocks immune-complex mediated inflammation in mice. Gene Ther. 2012; 19(9): 877-85[DOI][PubMed]
  • 14. Suda T, Kamimura K, Kubota T, Tamura Y, Igarashi M, Kawai H, et al. Progress toward liver-based gene therapy. Hepatol Res. 2009; 39(4): 325-40[DOI][PubMed]
  • 15. Zhang G, Song YK, Liu D. Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure. Gene Ther. 2000; 7(15): 1344-9[DOI][PubMed]
  • 16. Chen ZY, Yant SR, He CY, Meuse L, Shen S, Kay MA. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol Ther. 2001; 3(3): 403-10[DOI][PubMed]
  • 17. Ketzinel-Gilad M, Zauberman A, Nussbaum O, Shoshany Y, Ben-Moshe O, Pappo O, et al. The use of the hydrodynamic HBV animal model to study HBV biology and anti-viral therapy. Hepatol Res. 2006; 34(4): 228-37[DOI][PubMed]
  • 18. Yang D, Liu L, Zhu D, Peng H, Su L, Fu YX, et al. A mouse model for HBV immunotolerance and immunotherapy. Cell Mol Immunol. 2014; 11(1): 71-8[DOI][PubMed]
  • 19. Tzeng HT, Tsai HF, Chyuan IT, Liao HJ, Chen CJ, Chen PJ, et al. Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model. PLoS One. 2014; 9(7)[DOI][PubMed]
  • 20. Huang LR, Wu HL, Chen PJ, Chen DS. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A. 2006; 103(47): 17862-7[DOI][PubMed]
  • 21. Li L, Shen H, Li A, Zhang Z, Wang B, Wang J, et al. Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B. Virol J. 2013; 10: 214[DOI][PubMed]
  • 22. Division of Research Resources. Guide for the care and use of laboratory animals 1985;
  • 23. Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol. 2014; 20(18): 5427-34[DOI][PubMed]
  • 24. Xibing G, Xiaojuan Y, Juanhua W, Zhong H. Relationship between HBV genotypes B, C and follicular helper T cells in patients with chronic hepatitis B and its significance. Hepat Mon. 2013; 13(1)[DOI][PubMed]
  • 25. Dion S, Bourgine M, Godon O, Levillayer F, Michel ML. Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules. J Virol. 2013; 87(10): 5554-63[DOI][PubMed]
  • 26. Dang SS, Jia XL, Song P, Cheng YA, Zhang X, Sun MZ, et al. Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV. World J Gastroenterol. 2009; 15(45): 5669-73[PubMed]
  • 27. He Q, Tang Q, Le X, Lv D, Zhang X, Ao F, et al. The relationship between intrahepatic distribution of hepatitis B virus core antigen and serum ALT, HBV DNA levels and HBeAg Status. Infect Int (Electro Edit). 2012; 1: 84-90
  • 28. Chu CM, Shyu WC, Liaw YF. Immunopathology on hepatocyte expression of HBV surface, core, and x antigens in chronic hepatitis B: clinical and virological correlation. Dig Dis Sci. 2010; 55(2): 446-51[DOI][PubMed]
  • 29. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol. 2010; 52(4): 508-13[DOI][PubMed]
  • 30. Wang J, Wang B, Huang S, Song Z, Wu J, Zhang E, et al. Immunosuppressive drugs modulate the replication of hepatitis B virus (HBV) in a hydrodynamic injection mouse model. PLoS One. 2014; 9(1)[DOI][PubMed]
  • 31. Chao DC, Hu KQ. Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B. Drug Des Devel Ther. 2013; 7: 777-88[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader